Professional Experience
Alicia Russo has experience in complex patent litigation, biotechnology, bioinformatics, and pharmaceutical patent prosecution, licensing of intellectual property, patentability and non-infringement analysis, and complex patent litigation. Her primary focus is in the area of pharmaceuticals, chemicals, biotechnology, particularly in genetics, virology, biochemistry, molecular biology, bioinformatics and structural biology. She has a particular interest in structural genomics and has published articles and presented her thoughts at meetings relating to the patentability of structural information.
Ms. Russo's scientific career spanned 12 years and she is extensively published in noteworthy scientific journals, such as Science, Nature, Cell and the Proceedings of the National Academy of Sciences, with cover articles in both Nature and Cell. She has also presented her research at scientific meetings.
Professional Activities
American Intellectual Property Law Association; New York Intellectual Property Law Association (Chair of the Outreach Committee); American Chemical Society
Additional Publications
"Patenting 3-D Structures," Abstract for Presentation at the American Chemical Society (ACS) meeting in Boston, MA, August 18-22, 2002
"Patent Protection for Three-Dimensional Protein Structures May be Within Reach," Patent Strategy & Management, Volume 3, Number 2, June 2002
"Patenting 3D Protein Structures," Expert Opinion on Therapeutic Patents, February 2002
"The Current State of Embryonic Stem Cell Patents," The New York Law Journal, September 2001
Representative Cases
Amgen et al. v. Teva Pharmaceuticals, et al.
D. Del. 2011
Otsuka Pharmaceutical Co., Ltd., v. Sandoz Inc., et al.
D.N.J. 2010
Publications
Myriad Interpretations for Biological Patents
Intellectual Property Magazine
October 2011
Startup America: a commercialisation wakeup call for potentially dormant patented technology
Financier Worldwide
July 2011
The fate of biological patents: a Myriad analysis
Intellectual Property Magazine
June 2011
Federal Circuit Tightens Standard for Inequitable Conduct In Therasense v. Becton, Dickinson
Fitzpatrick Case Update
May 25, 2011
Stem Cells and Patenting and Related Regulatory Issues: A United States Perspective
Bio-Science Law Review
September/October 2005
Staking A Claim In The Nanoworld
Corporate Counsel
June 2004